MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Selegiline drives autophagic secretion of α-synuclein

    Y. Nakamura, S. Arawaka (Takatsuki, Japan)

  • Selenium mitigates ferroptosis-mediated dopaminergic cell death by regulating the Nrf2/GPX4 pathway: Implication for Parkinson’s disease

    YJ. Jung, H. Choi, E. Oh (Daejeon, Republic of Korea)

  • self-compassion, trait worry and sleep in parkinson’s disease (PD) patients

    M. Cusnir, S. Diaconu, E. Ungureanu, B. Ciopleiasb, R. Zosin, I. Murasan, C. Falup-Pecurariu (Brasov, Romania)

  • Self-perception of symptoms lateralization and association with symptoms severity in Parkinson’s disease.

    V. Silva Costa, T. Figo Rocha, M. Oliveira Menacho, T. Silva Brito, A. Lepesteur Gianlorenço (São Carlos, Brazil)

  • Self-report vs. informant-report of problematic behaviors using the Huntington’s Disease-Behavioral Questionnaire

    S. Hughes, E. Churchill, G. Parkin, B. Culbert, A. Smirnova, A. Hall, P. Gilbert, J. Corey-Bloom (San Diego, USA)

  • Sensitivity, consistency and test-retest reliability of home-based freezing of gait-provoking tests in people with Parkinson’s disease

    D. Zoetewei, P. Ginis, M. Gilat, T. Herman, M. Brozgol, P. Thumm, J. Hausdorff, A. Nieuwboer, N. D'Cruz (Leuven, Belgium)

  • Sensor-based digital measurement of gait and wrist pronation-supination in clinically-defined classes of Parkinson’s disease progression identified by unsupervised clustering

    D. Rodriguez Duque, J. Edgerton, L. Zhu, C. Kanzler, C. de Moor, S. Belachew, T. Dam, T. Liu, C. Shen, M. Yang, F. Nahab (Cambridge, USA)

  • Serotonin Coma: An Antipodal emergency

    K C. Chudasama, V J. Jhala (Rajkot, India)

  • Serum levels of IL-1β and interleukin 6 in Parkinson’s disease

    S. Fezai, M. Ben Mahmoud, S. Fray, H. Jamoussi, N. Ben Ali, M. Fredj (Tunis, Tunisia)

  • Serum Metabolomics in Parkinson’s Disease: Correlations with Fecal Microbiome, Fecal Metabolomics and Clinical Status

    TS. Toh, CW. Chong, MF. Loke, JW. Hor, LC. Lit, J. Bowman, SL. Song, CSJ. Teh, S-Y. Lim, AH. Tan (Kuala Lumpur, Malaysia)

  • « Previous Page
  • 1
  • …
  • 149
  • 150
  • 151
  • 152
  • 153
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley